Jun. 25 at 4:25 PM
$XLO 2025 upcoming catalysts and milestones.....seeking XTX 101 Vilastobart partnership by mid-year 2025.........Gilead XTX 301 development milestone
$17.5M ( prior to potential Phase 1/2 opt-in for
$75M) ......nominate development candidate for PSMA Q3 2025........Nominate development candidate for CLDN18.2 Q4 2025 ( both may trigger Abbvie milestone payments)